China SXT Pharmaceuticals (SXTC) Property, Plant & Equipment (Net) (2018 - 2026)
Powered by 
Analysis
China SXT Pharmaceuticals (SXTC) Property, Plant & Equipment (Net) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Property, Plant & Equipment (Net) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.95 Bn | 625.20 Bn | 17.26 Bn | 23.58 Bn |
| 2 | AbbVie | 441.39 Bn | 434.82 Bn | 12.70 Bn | 5.80 Bn |
| 3 | Merck | 366.72 Bn | 359.58 Bn | 12.21 Bn | 25.74 Bn |
| 4 | Novartis Ag | 266.68 Bn | 258.99 Bn | 11.24 Bn | 10.69 Bn |
| 5 | Pfizer | 159.20 Bn | 147.50 Bn | 10.94 Bn | 19.03 Bn |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn | 113.37 Bn |
| 7 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | 34.61 Mn |
| 8 | Incyte | 25.50 Bn | 20.96 Bn | 1.57 Bn | 709.47 Mn |
| 9 | United Therapeutics | 21.54 Bn | 18.88 Bn | 683.80 Mn | 1.93 Bn |
| 10 | China SXT Pharmaceuticals | 18,606.24 | -28.16 Mn | - | 117,103.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 117,103.00 |
| Sep 30, 2025 | 153,079.00 |
| Mar 31, 2025 | 178,561.00 |
| Sep 30, 2024 | 230,142.00 |
| Mar 31, 2024 | 328,845.00 |
| Sep 30, 2023 | 809,039.00 |
| Mar 31, 2023 | 962,214.00 |
| Sep 30, 2022 | 1.01 Mn |
| Mar 31, 2022 | 1.23 Mn |
| Sep 30, 2021 | 1.30 Mn |
| Mar 31, 2021 | 1.43 Mn |
| Sep 30, 2020 | 1.46 Mn |
| Mar 31, 2020 | 1.57 Mn |
| Sep 30, 2019 | 1.76 Mn |
| Mar 31, 2019 | 1.16 Mn |
| Sep 30, 2018 | 777,662.00 |
| Mar 31, 2018 | 862,453.00 |